Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Alpine Immune Sciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 88 | 1 | 133 | +46 |
| Shares | 45.9M | 6.71M | 58.9M | +19.7M (+50.3%) |
| Value | $525.8M | $76.8M | $1.12B | +$674.1M (+150.1%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (55)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (9)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Ghost Tree Capital, LLC | 664,132 | $7.60M |
| Avidity Partners Management LP | 657,280 | $7.53M |
| Tri Locum Partners LP | 314,029 | $3.60M |
| Omega Fund Management, LLC | 153,700 | $1.76M |
| Schonfeld Strategic Advisors LLC | 90,937 | $1.04M |
| Soleus Capital Management, L.P. | 88,073 | $1.01M |
| Moore Capital Management, LP | 13,744 | $157.4K |
| SG Americas Securities, LLC | 9,927 | $114.0K |
| Dorsey Wright & Associates | 2,273 | $26.0K |
Not filed for Q4 2023 yet (1)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76.8M |